Capital formation challenges in the industry have forced many biotech companies to halt projects, lay off staff or shutdown all together. Our analysis shows that the industry is approximately one-quarter smaller than it was in 2008.
|
June 29, 2011
|
June 28, 2011
|
June 27, 2011
|
June 27, 2011
|
|
June 22, 2011
|
June 21, 2011
|
June 20, 2011
|
June 17, 2011
|